Former P&G Director of North American Healthcare Customer Business Development Rick Schiano stepped into the role as OHCs’ CEO on Jan. 1, followed shortly by appointments of former P&G executives David Popp and Michael Leavy to roles as vice president of business operations and vice president of marketing, communication and business development, respectively.
“I’m a doctor, a medical oncologist. I do bone-marrow transplants, but I don’t do business. What I learned quickly was these business guys have a skill set. I brought [Schiano] in to run the business. He reports to me. One of our goals is that this be a physician-led, independent oncology group,” Randolph Broun, MD, chairman of the board of OHC and interim CEO, told the Cincinnati Business Courier.
OHC has 52 physicians. It is re-evaluating its growth strategy and considering acquiring other Ohio physician practices, according to the report.
More articles on integration and physician issues:
UC Riverside to launch residency program in Coachella Valley
Minnesota’s 10 guidelines to integrate foreign-trained physicians
5 outcomes of anesthesia practice consolidation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
